Abstract / Description of output
Glioblastoma (GBM) is an aggressive brain tumor whose growth is driven by stem cell-like cells. BMP signaling triggers cell-cycle exit and differentiation of GBM stem cells (GSCs) and, therefore, might have therapeutic value. However, the epigenetic mechanisms that accompany differentiation remain poorly defined. It is also unclear whether cell-cycle arrest is terminal. Here we find only a subset of GSC cultures exhibit astrocyte differentiation in response to BMP. Although overtly differentiated non-cycling astrocytes are generated, they remain vulnerable to cell-cycle re-entry and fail to appropriately reconfigure DNA methylation patterns. Chromatin accessibility mapping identified loci that failed to alter in response to BMP and these were enriched in SOX transcription factor-binding motifs. SOX transcription factors, therefore, may limit differentiation commitment. A similar propensity for cell-cycle re-entry and de-differentiation was observed in GSC-derived oligodendrocyte-like cells. These findings highlight significant obstacles to BMP-induced differentiation as therapy for GBM.
Original language | English |
---|---|
Pages (from-to) | 829–842 |
Journal | Stem Cell Reports |
Volume | 5 |
Issue number | 5 |
Early online date | 22 Dec 2015 |
DOIs | |
Publication status | E-pub ahead of print - 22 Dec 2015 |
Fingerprint
Dive into the research topics of 'Glioblastoma stem cells respond to differentiation cues but fail to undergo commitment and terminal cell cycle arrest'. Together they form a unique fingerprint.Profiles
-
Steven Pollard
- Deanery of Clinical Sciences - Personal Chair of Stem Cell and Cancer Biology
- Centre for Regenerative Medicine
- Edinburgh Neuroscience
- Centre for Engineering Biology
Person: Academic: Research Active